Press Release

AUDUBON, Pa.--(BUSINESS WIRE)--May. 9, 2013-- Globus Medical, Inc. (NYSE: GMED), a leading spinal implant manufacturer, today announced the launch of FORTIFY^® I, an expandable corpectomy spacer with integrated screws for further stability in addition to supplemental fixation.

“The FORTIFY^® I integrated expandable corpectomy spacer and instrument system provides surgeons with an innovative device for trauma and tumor indications, that is unmatched in its scope and versatility. This unique expandable technology allows for fixed and variable screw fixation through the endplates in a variety of minimally invasive surgical approach options from anterior to lateral, and adds new confidence in positional stability for the surgeon,” commented Andrew Iott, Senior Vice President, Global Product Development.

FORTIFY^® I, is an additional option in the Globus portfolio of expandable spacers. This system provides anterior column support for individual and multiple level corpectomy patients, and utilizes integrated screws, superior and inferior, that are designed to prevent dislodgement. The spacer is available in a variety of sagittal profiles and footprints for an optimized fit, and has integrated titanium plates and screws for additional stabilization between the vertebral bodies and spacer. The radiolucent PEEK implant options allow for postoperative visualization and have a modulus of elasticity closer to bone.

Indications for Use:

FORTIFY™ I Integrated Corpectomy Spacers (FORTIFY^® I and FORTIFY^® I-R) are vertebral body replacement devices intended for use in the thoracolumbar spine (T1-L-5) to replace a collapsed, damaged, or unstable vertebral body due to tumor or trauma (i.e., fracture). These devices are intended to be used with supplemental spinal fixation systems that have been labeled for use in the thoracic and/or lumbar spine (i.e., posterior pedicle screw and rod systems, anterior plate systems, and anterior screw and rod systems). The interior of the spacers can be packed with autogenous bone graft or allograft. These spacers are designed to provide anterior spinal column support even in the absence of fusion for a prolonged period.

About Globus Medical, Inc.

Globus Medical, Inc. is a leading spinal implant company based in Audubon, PA. The company was founded in 2003 by an experienced team of spine professionals with a shared vision to create products that enable spine surgeons to promote healing in patients with spinal disorders. Additional information can be accessed at www.globusmedical.com.

Safe Harbor Statements

All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Form 10-Q, Form 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.

Source: Globus Medical, Inc.

Globus Medical, Inc.
Ed Joyce, 610-930-1800
ejoyce@globusmedical.com
www.globusmedical.com